Skip to main content

Twitter Says It Accepts Elon Musk's October Trial Over $44 Billion Deal

Twitter Says It Accepts Elon Musk's October Trial

 Twitter said yes to a proposal by billionaire Elon Musk to start a trial on October 17 over Musk's bid to walk away from his $44 billion acquisition deal of the social media company. However, Twitter wants a commitment from Musk to complete the trial in five days. 

Twitter said in a court filing on Wednesday that Elon Musk has offered no assurance the trial would be completed in five days, as ordered by the judge, Kathaleen McCormick of the Delaware Court of Chancery. The San Francisco-based company wanted to complete the deal soon. 

Musk reportedly said he needs time to complete an investigation on Twitter's misrepresentation of fake accounts, which he said breached their deal terms.

Musk initially sought a February trial, but on Tuesday proposed an October 17 trial after a judge ruled that the trial was to start in three months. The trial in October will decide whether Elon Musk can be forced to complete his $44 billion deal to buy the social media platform. 

Recently, a judge in the eastern US state of Delaware ruled against Musk's push for a February date for the proceeding.

Elon Musk vs Twitter

Earlier, Musk’s lawyer told the Delaware Chancery Court that Musk wanted correct details about fake accounts on Twitter. However, Twitter said that Musk’s skepticism over Twitter's spam accounts tally was a distraction and asked to start the trial as soon as possible. Twitter argued that delay damages its business.

Musk reportedly backed away from the deal because the stocks of Twitter tumbled, and the value had fallen below the $54.20 per share he offered. Earlier, Musk had made a hostile bid to take over Twitter for a $44 billion deal, which means Musk agreed to acquire the company for $54.20 a share. On Wednesday, the shares of Twitter closed up 1.3 percent at $39.85. 




Comments

Popular posts from this blog

Netanyahu’s Shocking Gaza Plan: ‘We Will Take Control of ALL of Gaza’ — But At What Cost?

  As Israeli forces intensify their offensive, Netanyahu vows total control of Gaza — but the humanitarian crisis is reaching a breaking point. Will the world stand by and watch? Israeli Prime Minister Benjamin Netanyahu has declared that Israel will “take control of all” of the Gaza Strip, signaling an unprecedented escalation in the ongoing conflict. In a video posted to Telegram, Netanyahu emphasized that military operations are advancing rapidly, with no intention of backing down. “The fighting is intense, and we are making progress,” he said, framing the offensive as necessary for Israel’s long-term security. But as international pressure mounts, his government is walking a tightrope between military dominance and global condemnation. The Israeli military has ordered mass evacuations in southern Gaza, warning residents of Khan Yunis and surrounding areas to flee immediately ahead of a devastating assault. Arabic-language spokesman Avichay Adraee described the coming attack as ...

Israel issues latest forced evacuation order in areas in Khan Younis

  The Israeli army’s Arabic-language spokesperson, Avichay Adraee, has issued the latest forced evacuation order for civilians living in nine areas in Khan Younis, southern Gaza. Adraee said that the army was expanding its operation and “intensifying sudden and concentrated firepower”. The spokesperson called on residents to evacuate westward. So-called Israeli safe zones, including Al-Mawasi in Khan Younis, are routinely attacked despite the army forcing Palestinians to move to those areas.

UAE initiates extensive CAR T-cell treatment in the region

The United Arab Emirates has transformed the medical structure of the region as it slowly moves towards attaining leadership in medical treatments and complex procedures. It has stepped up on the list with a pioneering treatment led by Abu Dhabi. The capital has witnessed a revolutionary process that focuses on the safety and efficacy of using the CAR T-Cell treatment module especially for hematologic or blood cancers such as lymphoma, myeloma, and certain types of leukemia. This is an exemplary step in the context of the region as it is the first of its kind treatment here.  On Saturday, the Emirati nation began its experiment to locally manufacture CAR T-Cell treatment at Abu Dhabi Stem Cells Center. The T-Cells will be locally reprogrammed and tested for their effectiveness so that they get better results when it comes to treating cancer.   The unit for the stem cell treatment ADSCC was founded in 2019 and since then it has grown threefold when it comes to experimenting wit...